Cargando…
AAV9 gene transfer of cMyBPC N-terminal domains ameliorates cardiomyopathy in cMyBPC-deficient mice
Decreased cardiac myosin-binding protein C (cMyBPC) expression due to inheritable mutations is thought to contribute to the hypertrophic cardiomyopathy (HCM) phenotype, suggesting that increasing cMyBPC content is of therapeutic benefit. In vitro assays show that cMyBPC N-terminal domains (NTDs) con...
Autores principales: | Li, Jiayang, Mamidi, Ranganath, Doh, Chang Yoon, Holmes, Joshua B., Bharambe, Nikhil, Ramachandran, Rajesh, Stelzer, Julian E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526450/ https://www.ncbi.nlm.nih.gov/pubmed/32750038 http://dx.doi.org/10.1172/jci.insight.130182 |
Ejemplares similares
-
cMyBPC phosphorylation modulates the effect of omecamtiv mecarbil on myocardial force generation
por: Mamidi, Ranganath, et al.
Publicado: (2021) -
The contribution of N-terminal truncated cMyBPC to in vivo cardiac function
por: Dominic, Katherine L., et al.
Publicado: (2023) -
cMyBPC phosphorylation alters response to heart failure drug
por: Short, Ben
Publicado: (2021) -
Unofficial Formulary, B.P.C.
Publicado: (1888) -
Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198
por: Cirac, Anna D., et al.
Publicado: (2017)